nodes	percent_of_prediction	percent_of_DWPC	metapath
Venlafaxine—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.568	1	CbGbCtD
Venlafaxine—NPY1R—nerve—amyotrophic lateral sclerosis	0.00692	0.176	CbGeAlD
Venlafaxine—Major depression—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0133	CcSEcCtD
Venlafaxine—Salivary gland enlargement—Riluzole—amyotrophic lateral sclerosis	0.00455	0.0129	CcSEcCtD
Venlafaxine—Rheumatoid arthritis—Riluzole—amyotrophic lateral sclerosis	0.00419	0.0118	CcSEcCtD
Venlafaxine—Facial paralysis—Riluzole—amyotrophic lateral sclerosis	0.00397	0.0112	CcSEcCtD
Venlafaxine—Circumoral paresthesia—Riluzole—amyotrophic lateral sclerosis	0.00388	0.011	CcSEcCtD
Venlafaxine—Trismus—Riluzole—amyotrophic lateral sclerosis	0.00379	0.0107	CcSEcCtD
Venlafaxine—Uterine haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00362	0.0102	CcSEcCtD
Venlafaxine—Hypoventilation—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00959	CcSEcCtD
Venlafaxine—Hyperacusis—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00959	CcSEcCtD
Venlafaxine—Pyelonephritis—Riluzole—amyotrophic lateral sclerosis	0.00332	0.0094	CcSEcCtD
Venlafaxine—Manic psychosis—Riluzole—amyotrophic lateral sclerosis	0.0032	0.00904	CcSEcCtD
Venlafaxine—Yawning—Riluzole—amyotrophic lateral sclerosis	0.00314	0.00887	CcSEcCtD
Venlafaxine—Dementia—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00871	CcSEcCtD
Venlafaxine—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00308	0.00871	CcSEcCtD
Venlafaxine—Furunculosis—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00841	CcSEcCtD
Venlafaxine—Paranoid reaction—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00841	CcSEcCtD
Venlafaxine—Cheilitis—Riluzole—amyotrophic lateral sclerosis	0.00297	0.00841	CcSEcCtD
Venlafaxine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.00291	0.0739	CbGeAlD
Venlafaxine—Paraesthesia oral—Riluzole—amyotrophic lateral sclerosis	0.0027	0.00762	CcSEcCtD
Venlafaxine—Cerebral ischaemia—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00739	CcSEcCtD
Venlafaxine—Tongue discolouration—Riluzole—amyotrophic lateral sclerosis	0.00262	0.00739	CcSEcCtD
Venlafaxine—Furuncle—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00729	CcSEcCtD
Venlafaxine—Peripheral vascular disorder—Riluzole—amyotrophic lateral sclerosis	0.00258	0.00729	CcSEcCtD
Venlafaxine—Pneumothorax—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00718	CcSEcCtD
Venlafaxine—Muscle relaxant therapy—Riluzole—amyotrophic lateral sclerosis	0.00254	0.00718	CcSEcCtD
Venlafaxine—Bundle branch block—Riluzole—amyotrophic lateral sclerosis	0.0025	0.00708	CcSEcCtD
Venlafaxine—Renal pain—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0068	CcSEcCtD
Venlafaxine—Hypotonia—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0068	CcSEcCtD
Venlafaxine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00235	0.0596	CbGeAlD
Venlafaxine—Urine abnormality—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00645	CcSEcCtD
Venlafaxine—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00228	0.00645	CcSEcCtD
Venlafaxine—Osteoporosis—Riluzole—amyotrophic lateral sclerosis	0.00225	0.00637	CcSEcCtD
Venlafaxine—Micturition urgency—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0063	CcSEcCtD
Venlafaxine—Gingival bleeding—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0063	CcSEcCtD
Venlafaxine—Suicide attempt—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0063	CcSEcCtD
Venlafaxine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.0022	0.00622	CcSEcCtD
Venlafaxine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00218	0.0553	CbGeAlD
Venlafaxine—Urine analysis abnormal—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00608	CcSEcCtD
Venlafaxine—Completed suicide—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00608	CcSEcCtD
Venlafaxine—Myoclonus—Riluzole—amyotrophic lateral sclerosis	0.0021	0.00594	CcSEcCtD
Venlafaxine—Libido increased—Riluzole—amyotrophic lateral sclerosis	0.00208	0.00587	CcSEcCtD
Venlafaxine—Blepharitis—Riluzole—amyotrophic lateral sclerosis	0.00205	0.00581	CcSEcCtD
Venlafaxine—Psoriasis—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00568	CcSEcCtD
Venlafaxine—Myasthenia—Riluzole—amyotrophic lateral sclerosis	0.00201	0.00568	CcSEcCtD
Venlafaxine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.002	0.0507	CbGeAlD
Venlafaxine—Oral candidiasis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00563	CcSEcCtD
Venlafaxine—Hypoxia—Riluzole—amyotrophic lateral sclerosis	0.00199	0.00563	CcSEcCtD
Venlafaxine—Calculus of kidney—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00545	CcSEcCtD
Venlafaxine—Supraventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00193	0.00545	CcSEcCtD
Venlafaxine—Cyst—Riluzole—amyotrophic lateral sclerosis	0.00189	0.00535	CcSEcCtD
Venlafaxine—Hypokinesia—Riluzole—amyotrophic lateral sclerosis	0.00187	0.00529	CcSEcCtD
Venlafaxine—Intestinal obstruction—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00524	CcSEcCtD
Venlafaxine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00524	CcSEcCtD
Venlafaxine—Seborrhoeic dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00185	0.00524	CcSEcCtD
Venlafaxine—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00519	CcSEcCtD
Venlafaxine—Hyperventilation—Riluzole—amyotrophic lateral sclerosis	0.00184	0.00519	CcSEcCtD
Venlafaxine—Haematemesis—Riluzole—amyotrophic lateral sclerosis	0.00182	0.00514	CcSEcCtD
Venlafaxine—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0018	0.0051	CcSEcCtD
Venlafaxine—Lung disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00505	CcSEcCtD
Venlafaxine—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00505	CcSEcCtD
Venlafaxine—Interstitial lung disease—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00505	CcSEcCtD
Venlafaxine—Cyanosis—Riluzole—amyotrophic lateral sclerosis	0.00179	0.00505	CcSEcCtD
Venlafaxine—Apathy—Riluzole—amyotrophic lateral sclerosis	0.00177	0.005	CcSEcCtD
Venlafaxine—Metrorrhagia—Riluzole—amyotrophic lateral sclerosis	0.00177	0.005	CcSEcCtD
Venlafaxine—Laryngitis—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00496	CcSEcCtD
Venlafaxine—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00175	0.00496	CcSEcCtD
Venlafaxine—Mania—Riluzole—amyotrophic lateral sclerosis	0.00174	0.00491	CcSEcCtD
Venlafaxine—Haemoptysis—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00483	CcSEcCtD
Venlafaxine—Stupor—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00479	CcSEcCtD
Venlafaxine—Neuritis—Riluzole—amyotrophic lateral sclerosis	0.00169	0.00479	CcSEcCtD
Venlafaxine—Glaucoma—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00475	CcSEcCtD
Venlafaxine—Extrapyramidal disorder—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00475	CcSEcCtD
Venlafaxine—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00165	0.00467	CcSEcCtD
Venlafaxine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00157	0.00445	CcSEcCtD
Venlafaxine—Ageusia—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00441	CcSEcCtD
Venlafaxine—Glycosuria—Riluzole—amyotrophic lateral sclerosis	0.00156	0.00441	CcSEcCtD
Venlafaxine—NPY1R—nervous system—amyotrophic lateral sclerosis	0.00156	0.0395	CbGeAlD
Venlafaxine—Petechiae—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00434	CcSEcCtD
Venlafaxine—Liver injury—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00425	CcSEcCtD
Venlafaxine—NPY1R—central nervous system—amyotrophic lateral sclerosis	0.0015	0.038	CbGeAlD
Venlafaxine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00147	0.00415	CcSEcCtD
Venlafaxine—Breast pain—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0041	CcSEcCtD
Venlafaxine—Amenorrhoea—Riluzole—amyotrophic lateral sclerosis	0.00144	0.00407	CcSEcCtD
Venlafaxine—Accidental injury—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00404	CcSEcCtD
Venlafaxine—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00398	CcSEcCtD
Venlafaxine—Ventricular extrasystoles—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00396	CcSEcCtD
Venlafaxine—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00393	CcSEcCtD
Venlafaxine—Cellulitis—Riluzole—amyotrophic lateral sclerosis	0.00139	0.00393	CcSEcCtD
Venlafaxine—Cough increased—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0039	CcSEcCtD
Venlafaxine—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.00138	0.0039	CcSEcCtD
Venlafaxine—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.00137	0.00388	CcSEcCtD
Venlafaxine—Nocturia—Riluzole—amyotrophic lateral sclerosis	0.00136	0.00385	CcSEcCtD
Venlafaxine—Gout—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00383	CcSEcCtD
Venlafaxine—Leukocytosis—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0038	CcSEcCtD
Venlafaxine—Hypercholesterolaemia—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00378	CcSEcCtD
Venlafaxine—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00375	CcSEcCtD
Venlafaxine—Gait disturbance—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00366	CcSEcCtD
Venlafaxine—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00364	CcSEcCtD
Venlafaxine—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00129	0.00364	CcSEcCtD
Venlafaxine—Neck pain—Riluzole—amyotrophic lateral sclerosis	0.00128	0.00362	CcSEcCtD
Venlafaxine—Hiccups—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00357	CcSEcCtD
Venlafaxine—Hepatocellular injury—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00357	CcSEcCtD
Venlafaxine—Ventricular tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00357	CcSEcCtD
Venlafaxine—Phosphatase alkaline increased—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00357	CcSEcCtD
Venlafaxine—Pulmonary embolism—Riluzole—amyotrophic lateral sclerosis	0.00126	0.00357	CcSEcCtD
Venlafaxine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00125	0.0317	CbGeAlD
Venlafaxine—Dermatitis contact—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00353	CcSEcCtD
Venlafaxine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00125	0.00353	CcSEcCtD
Venlafaxine—Melaena—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00349	CcSEcCtD
Venlafaxine—Urinary incontinence—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00345	CcSEcCtD
Venlafaxine—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00345	CcSEcCtD
Venlafaxine—Candida infection—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00341	CcSEcCtD
Venlafaxine—NPY1R—brain—amyotrophic lateral sclerosis	0.00119	0.0302	CbGeAlD
Venlafaxine—Aplastic anaemia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00335	CcSEcCtD
Venlafaxine—Photophobia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00335	CcSEcCtD
Venlafaxine—Cramps of lower extremities—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00328	CcSEcCtD
Venlafaxine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00114	0.0291	CbGeAlD
Venlafaxine—Ecchymosis—Riluzole—amyotrophic lateral sclerosis	0.00114	0.00323	CcSEcCtD
Venlafaxine—Hypertonia—Riluzole—amyotrophic lateral sclerosis	0.00111	0.00313	CcSEcCtD
Venlafaxine—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.0011	0.0031	CcSEcCtD
Venlafaxine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00109	0.00307	CcSEcCtD
Venlafaxine—Lymphadenopathy—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00304	CcSEcCtD
Venlafaxine—Diabetes mellitus—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00298	CcSEcCtD
Venlafaxine—Blood alkaline phosphatase increased—Riluzole—amyotrophic lateral sclerosis	0.00105	0.00298	CcSEcCtD
Venlafaxine—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0029	CcSEcCtD
Venlafaxine—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00103	0.0029	CcSEcCtD
Venlafaxine—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00102	0.00289	CcSEcCtD
Venlafaxine—Cardiac failure congestive—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00286	CcSEcCtD
Venlafaxine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00101	0.0256	CbGeAlD
Venlafaxine—Injury—Riluzole—amyotrophic lateral sclerosis	0.000998	0.00282	CcSEcCtD
Venlafaxine—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.000989	0.0028	CcSEcCtD
Venlafaxine—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00276	CcSEcCtD
Venlafaxine—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.000977	0.00276	CcSEcCtD
Venlafaxine—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.000972	0.00275	CcSEcCtD
Venlafaxine—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.000968	0.00274	CcSEcCtD
Venlafaxine—Thirst—Riluzole—amyotrophic lateral sclerosis	0.000964	0.00273	CcSEcCtD
Venlafaxine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.000963	0.0244	CbGeAlD
Venlafaxine—Purpura—Riluzole—amyotrophic lateral sclerosis	0.000952	0.00269	CcSEcCtD
Venlafaxine—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.000944	0.00267	CcSEcCtD
Venlafaxine—Hyponatraemia—Riluzole—amyotrophic lateral sclerosis	0.000921	0.0026	CcSEcCtD
Venlafaxine—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00259	CcSEcCtD
Venlafaxine—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00259	CcSEcCtD
Venlafaxine—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.000917	0.00259	CcSEcCtD
Venlafaxine—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00091	0.00257	CcSEcCtD
Venlafaxine—Migraine—Riluzole—amyotrophic lateral sclerosis	0.000903	0.00255	CcSEcCtD
Venlafaxine—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.000903	0.00255	CcSEcCtD
Venlafaxine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.000896	0.00253	CcSEcCtD
Venlafaxine—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.000886	0.0025	CcSEcCtD
Venlafaxine—Cardiac arrest—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00247	CcSEcCtD
Venlafaxine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.000872	0.00247	CcSEcCtD
Venlafaxine—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.000869	0.00246	CcSEcCtD
Venlafaxine—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.000863	0.00244	CcSEcCtD
Venlafaxine—Dehydration—Riluzole—amyotrophic lateral sclerosis	0.000853	0.00241	CcSEcCtD
Venlafaxine—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.000847	0.00239	CcSEcCtD
Venlafaxine—Orthostatic hypotension—Riluzole—amyotrophic lateral sclerosis	0.000838	0.00237	CcSEcCtD
Venlafaxine—Hypokalaemia—Riluzole—amyotrophic lateral sclerosis	0.000835	0.00236	CcSEcCtD
Venlafaxine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000826	0.00234	CcSEcCtD
Venlafaxine—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.000812	0.0023	CcSEcCtD
Venlafaxine—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00229	CcSEcCtD
Venlafaxine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00229	CcSEcCtD
Venlafaxine—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.000798	0.00226	CcSEcCtD
Venlafaxine—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00224	CcSEcCtD
Venlafaxine—Asthma—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00224	CcSEcCtD
Venlafaxine—Influenza—Riluzole—amyotrophic lateral sclerosis	0.000793	0.00224	CcSEcCtD
Venlafaxine—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.000777	0.0022	CcSEcCtD
Venlafaxine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.000777	0.0197	CbGeAlD
Venlafaxine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.000772	0.00218	CcSEcCtD
Venlafaxine—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.000763	0.00216	CcSEcCtD
Venlafaxine—Pancytopenia—Riluzole—amyotrophic lateral sclerosis	0.000753	0.00213	CcSEcCtD
Venlafaxine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.000741	0.0021	CcSEcCtD
Venlafaxine—Neutropenia—Riluzole—amyotrophic lateral sclerosis	0.000741	0.0021	CcSEcCtD
Venlafaxine—Pollakiuria—Riluzole—amyotrophic lateral sclerosis	0.000733	0.00207	CcSEcCtD
Venlafaxine—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00073	0.00206	CcSEcCtD
Venlafaxine—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.000724	0.00205	CcSEcCtD
Venlafaxine—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.000722	0.00204	CcSEcCtD
Venlafaxine—Weight decreased—Riluzole—amyotrophic lateral sclerosis	0.000717	0.00203	CcSEcCtD
Venlafaxine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.000712	0.0181	CbGeAlD
Venlafaxine—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.000711	0.00201	CcSEcCtD
Venlafaxine—Depression—Riluzole—amyotrophic lateral sclerosis	0.000705	0.00199	CcSEcCtD
Venlafaxine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.000703	0.0178	CbGeAlD
Venlafaxine—Acute coronary syndrome—Riluzole—amyotrophic lateral sclerosis	0.000697	0.00197	CcSEcCtD
Venlafaxine—Myocardial infarction—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00196	CcSEcCtD
Venlafaxine—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.000693	0.00196	CcSEcCtD
Venlafaxine—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00195	CcSEcCtD
Venlafaxine—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.000689	0.00195	CcSEcCtD
Venlafaxine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.000678	0.00192	CcSEcCtD
Venlafaxine—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.000674	0.00191	CcSEcCtD
Venlafaxine—Epistaxis—Riluzole—amyotrophic lateral sclerosis	0.000667	0.00189	CcSEcCtD
Venlafaxine—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.000663	0.00188	CcSEcCtD
Venlafaxine—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.00066	0.00187	CcSEcCtD
Venlafaxine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.000655	0.0166	CbGeAlD
Venlafaxine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00183	CcSEcCtD
Venlafaxine—Haemoglobin—Riluzole—amyotrophic lateral sclerosis	0.000638	0.0018	CcSEcCtD
Venlafaxine—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.000636	0.0018	CcSEcCtD
Venlafaxine—Haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00179	CcSEcCtD
Venlafaxine—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00179	CcSEcCtD
Venlafaxine—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00179	CcSEcCtD
Venlafaxine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.000632	0.00179	CcSEcCtD
Venlafaxine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00063	0.016	CbGeAlD
Venlafaxine—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00063	0.00178	CcSEcCtD
Venlafaxine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.000616	0.0156	CbGeAlD
Venlafaxine—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0006	0.0017	CcSEcCtD
Venlafaxine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.0006	0.0152	CbGeAlD
Venlafaxine—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.000589	0.00167	CcSEcCtD
Venlafaxine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.000577	0.0147	CbGeAlD
Venlafaxine—Chills—Riluzole—amyotrophic lateral sclerosis	0.000569	0.00161	CcSEcCtD
Venlafaxine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.000567	0.0016	CcSEcCtD
Venlafaxine—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000561	0.0143	CbGeAlD
Venlafaxine—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.000561	0.00159	CcSEcCtD
Venlafaxine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.000552	0.014	CbGeAlD
Venlafaxine—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.000544	0.00154	CcSEcCtD
Venlafaxine—Tension—Riluzole—amyotrophic lateral sclerosis	0.000542	0.00153	CcSEcCtD
Venlafaxine—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.000541	0.00153	CcSEcCtD
Venlafaxine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.000537	0.00152	CcSEcCtD
Venlafaxine—Back pain—Riluzole—amyotrophic lateral sclerosis	0.000534	0.00151	CcSEcCtD
Venlafaxine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000531	0.0015	CcSEcCtD
Venlafaxine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.000528	0.0134	CbGeAlD
Venlafaxine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.000518	0.00146	CcSEcCtD
Venlafaxine—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.000513	0.00145	CcSEcCtD
Venlafaxine—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000511	0.00144	CcSEcCtD
Venlafaxine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.000508	0.0129	CbGeAlD
Venlafaxine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000508	0.00144	CcSEcCtD
Venlafaxine—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.000505	0.00143	CcSEcCtD
Venlafaxine—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000501	0.0127	CbGeAlD
Venlafaxine—SLC6A3—brain—amyotrophic lateral sclerosis	0.0005	0.0127	CbGeAlD
Venlafaxine—Malaise—Riluzole—amyotrophic lateral sclerosis	0.000498	0.00141	CcSEcCtD
Venlafaxine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.000496	0.0014	CcSEcCtD
Venlafaxine—Syncope—Riluzole—amyotrophic lateral sclerosis	0.000495	0.0014	CcSEcCtD
Venlafaxine—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000495	0.0014	CcSEcCtD
Venlafaxine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.000488	0.00138	CcSEcCtD
Venlafaxine—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.000486	0.00137	CcSEcCtD
Venlafaxine—Cough—Riluzole—amyotrophic lateral sclerosis	0.000482	0.00136	CcSEcCtD
Venlafaxine—NPY1R—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.00048	0.0124	CbGpPWpGaD
Venlafaxine—Convulsion—Riluzole—amyotrophic lateral sclerosis	0.000479	0.00135	CcSEcCtD
Venlafaxine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.000477	0.00135	CcSEcCtD
Venlafaxine—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00047	0.00133	CcSEcCtD
Venlafaxine—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00047	0.00133	CcSEcCtD
Venlafaxine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00047	0.00133	CcSEcCtD
Venlafaxine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000469	0.00133	CcSEcCtD
Venlafaxine—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.000465	0.00131	CcSEcCtD
Venlafaxine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00046	0.0013	CcSEcCtD
Venlafaxine—SLC6A4—brain—amyotrophic lateral sclerosis	0.000458	0.0116	CbGeAlD
Venlafaxine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.000455	0.00129	CcSEcCtD
Venlafaxine—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00127	CcSEcCtD
Venlafaxine—Oedema—Riluzole—amyotrophic lateral sclerosis	0.000451	0.00127	CcSEcCtD
Venlafaxine—Infection—Riluzole—amyotrophic lateral sclerosis	0.000448	0.00127	CcSEcCtD
Venlafaxine—Shock—Riluzole—amyotrophic lateral sclerosis	0.000444	0.00125	CcSEcCtD
Venlafaxine—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000442	0.00125	CcSEcCtD
Venlafaxine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00044	0.00124	CcSEcCtD
Venlafaxine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.000436	0.00123	CcSEcCtD
Venlafaxine—ABCB1—embryo—amyotrophic lateral sclerosis	0.000433	0.011	CbGeAlD
Venlafaxine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00043	0.00122	CcSEcCtD
Venlafaxine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000423	0.0109	CbGpPWpGaD
Venlafaxine—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000421	0.00119	CcSEcCtD
Venlafaxine—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.000411	0.00116	CcSEcCtD
Venlafaxine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000408	0.00115	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.000405	0.0104	CbGpPWpGaD
Venlafaxine—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.000405	0.00114	CcSEcCtD
Venlafaxine—SLC6A2—brain—amyotrophic lateral sclerosis	0.000404	0.0102	CbGeAlD
Venlafaxine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.000402	0.00114	CcSEcCtD
Venlafaxine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000401	0.00113	CcSEcCtD
Venlafaxine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.000397	0.00112	CcSEcCtD
Venlafaxine—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000397	0.0101	CbGeAlD
Venlafaxine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000395	0.0102	CbGpPWpGaD
Venlafaxine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000392	0.00111	CcSEcCtD
Venlafaxine—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.000389	0.00988	CbGeAlD
Venlafaxine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000389	0.0011	CcSEcCtD
Venlafaxine—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00109	CcSEcCtD
Venlafaxine—Pain—Riluzole—amyotrophic lateral sclerosis	0.000386	0.00109	CcSEcCtD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000382	0.00983	CbGpPWpGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—CASP9—amyotrophic lateral sclerosis	0.000378	0.00973	CbGpPWpGaD
Venlafaxine—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.000375	0.00951	CbGeAlD
Venlafaxine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000372	0.00105	CcSEcCtD
Venlafaxine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.000369	0.00104	CcSEcCtD
Venlafaxine—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000358	0.00101	CcSEcCtD
Venlafaxine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.000356	0.00101	CcSEcCtD
Venlafaxine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000356	0.00101	CcSEcCtD
Venlafaxine—SLC6A4—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000335	0.00863	CbGpPWpGaD
Venlafaxine—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000332	0.000939	CcSEcCtD
Venlafaxine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000324	0.000915	CcSEcCtD
Venlafaxine—ABCG2—brain—amyotrophic lateral sclerosis	0.000322	0.00819	CbGeAlD
Venlafaxine—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000319	0.000902	CcSEcCtD
Venlafaxine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000309	0.000872	CcSEcCtD
Venlafaxine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000298	0.000843	CcSEcCtD
Venlafaxine—CYP2B6—brain—amyotrophic lateral sclerosis	0.000297	0.00755	CbGeAlD
Venlafaxine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000294	0.00746	CbGeAlD
Venlafaxine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000293	0.00754	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000291	0.00748	CbGpPWpGaD
Venlafaxine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000289	0.00734	CbGeAlD
Venlafaxine—SLC6A2—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000288	0.00742	CbGpPWpGaD
Venlafaxine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000287	0.000811	CcSEcCtD
Venlafaxine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000284	0.000804	CcSEcCtD
Venlafaxine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000284	0.000803	CcSEcCtD
Venlafaxine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000283	0.00718	CbGeAlD
Venlafaxine—Headache—Riluzole—amyotrophic lateral sclerosis	0.000282	0.000799	CcSEcCtD
Venlafaxine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000278	0.00707	CbGeAlD
Venlafaxine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000277	0.00703	CbGeAlD
Venlafaxine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000272	0.00691	CbGeAlD
Venlafaxine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000268	0.000757	CcSEcCtD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000261	0.00672	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000261	0.00672	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000261	0.00672	CbGpPWpGaD
Venlafaxine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000261	0.00671	CbGpPWpGaD
Venlafaxine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000259	0.00668	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—GSR—amyotrophic lateral sclerosis	0.000255	0.00658	CbGpPWpGaD
Venlafaxine—NPY1R—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.000248	0.00639	CbGpPWpGaD
Venlafaxine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000247	0.00627	CbGeAlD
Venlafaxine—SLC6A4—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000245	0.00632	CbGpPWpGaD
Venlafaxine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000221	0.00561	CbGeAlD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000215	0.00554	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000211	0.00543	CbGpPWpGaD
Venlafaxine—NPY1R—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00021	0.00539	CbGpPWpGaD
Venlafaxine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000208	0.00528	CbGeAlD
Venlafaxine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.0002	0.00508	CbGeAlD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000199	0.00511	CbGpPWpGaD
Venlafaxine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000196	0.00497	CbGeAlD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000192	0.00494	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000189	0.00487	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—SLC6A1—amyotrophic lateral sclerosis	0.000187	0.00481	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—CST3—amyotrophic lateral sclerosis	0.00018	0.00463	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000175	0.00452	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000175	0.00452	CbGpPWpGaD
Venlafaxine—NPY1R—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000167	0.00429	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000165	0.00424	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000164	0.00423	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000163	0.0042	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000163	0.0042	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000163	0.00419	CbGpPWpGaD
Venlafaxine—SLC6A3—Parkinsons Disease Pathway—CASP3—amyotrophic lateral sclerosis	0.000159	0.0041	CbGpPWpGaD
Venlafaxine—ABCB1—brain—amyotrophic lateral sclerosis	0.000159	0.00404	CbGeAlD
Venlafaxine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000158	0.00407	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000155	0.004	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000152	0.00392	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000149	0.00384	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000149	0.00384	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000149	0.00383	CbGpPWpGaD
Venlafaxine—SLC6A4—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000148	0.00381	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000147	0.00378	CbGpPWpGaD
Venlafaxine—CYP2D6—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.000145	0.00375	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000145	0.00374	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000144	0.00371	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000138	0.00356	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	0.000136	0.00349	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000135	0.00348	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000134	0.00346	CbGpPWpGaD
Venlafaxine—SLC6A2—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000133	0.00342	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000132	0.0034	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00013	0.00336	CbGpPWpGaD
Venlafaxine—SLC6A2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000127	0.00328	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000127	0.00327	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000125	0.00322	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000125	0.00322	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000124	0.0032	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000123	0.00316	CbGpPWpGaD
Venlafaxine—SLC6A3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000118	0.00303	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000116	0.00299	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000113	0.00292	CbGpPWpGaD
Venlafaxine—SLC6A3—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000113	0.0029	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000113	0.0029	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000113	0.0029	CbGpPWpGaD
Venlafaxine—SLC6A3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000111	0.00287	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000109	0.00281	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000106	0.00274	CbGpPWpGaD
Venlafaxine—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	0.000105	0.0027	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	0.000105	0.00269	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000104	0.00267	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000103	0.00266	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000103	0.00264	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.0001	0.00258	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.92e-05	0.0023	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.91e-05	0.00229	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.81e-05	0.00227	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.66e-05	0.00223	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	8.42e-05	0.00217	CbGpPWpGaD
Venlafaxine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	7.98e-05	0.00206	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.92e-05	0.00204	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.9e-05	0.00203	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.9e-05	0.00203	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.58e-05	0.00195	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.58e-05	0.00195	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	7.44e-05	0.00191	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.37e-05	0.0019	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.37e-05	0.0019	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	7.31e-05	0.00188	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.26e-05	0.00187	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.22e-05	0.00186	CbGpPWpGaD
Venlafaxine—NPY1R—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.17e-05	0.00185	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	7.1e-05	0.00183	CbGpPWpGaD
Venlafaxine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	7.01e-05	0.0018	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	6.97e-05	0.00179	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	6.97e-05	0.00179	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.93e-05	0.00178	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.77e-05	0.00174	CbGpPWpGaD
Venlafaxine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.76e-05	0.00174	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	6.75e-05	0.00174	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.72e-05	0.00173	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.72e-05	0.00173	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.72e-05	0.00173	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	6.68e-05	0.00172	CbGpPWpGaD
Venlafaxine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.66e-05	0.00172	CbGpPWpGaD
Venlafaxine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.57e-05	0.00169	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.51e-05	0.00168	CbGpPWpGaD
Venlafaxine—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.39e-05	0.00165	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.37e-05	0.00164	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.31e-05	0.00163	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.18e-05	0.00159	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.18e-05	0.00159	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.09e-05	0.00157	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.05e-05	0.00156	CbGpPWpGaD
Venlafaxine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.99e-05	0.00154	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.92e-05	0.00152	CbGpPWpGaD
Venlafaxine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	5.73e-05	0.00147	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.68e-05	0.00146	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.57e-05	0.00143	CbGpPWpGaD
Venlafaxine—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.5e-05	0.00142	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.41e-05	0.00139	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	5.16e-05	0.00133	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	5.11e-05	0.00131	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	5.11e-05	0.00131	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	5.04e-05	0.0013	CbGpPWpGaD
Venlafaxine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.03e-05	0.0013	CbGpPWpGaD
Venlafaxine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.97e-05	0.00128	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.75e-05	0.00122	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.67e-05	0.0012	CbGpPWpGaD
Venlafaxine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.63e-05	0.00119	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.63e-05	0.00119	CbGpPWpGaD
Venlafaxine—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.59e-05	0.00118	CbGpPWpGaD
Venlafaxine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.57e-05	0.00118	CbGpPWpGaD
Venlafaxine—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.53e-05	0.00117	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	4.4e-05	0.00113	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.35e-05	0.00112	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	4.35e-05	0.00112	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.34e-05	0.00112	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.33e-05	0.00111	CbGpPWpGaD
Venlafaxine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.32e-05	0.00111	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	4.15e-05	0.00107	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.08e-05	0.00105	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.93e-05	0.00101	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	3.86e-05	0.000993	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	3.86e-05	0.000993	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.85e-05	0.00099	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.82e-05	0.000983	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.77e-05	0.00097	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.77e-05	0.00097	CbGpPWpGaD
Venlafaxine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.74e-05	0.000962	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.69e-05	0.00095	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.6e-05	0.000926	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.58e-05	0.000922	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.55e-05	0.000914	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.55e-05	0.000914	CbGpPWpGaD
Venlafaxine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	3.53e-05	0.00091	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	3.53e-05	0.000909	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	3.52e-05	0.000907	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	3.52e-05	0.000906	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	3.52e-05	0.000906	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.44e-05	0.000887	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.34e-05	0.00086	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.34e-05	0.00086	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.28e-05	0.000845	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.28e-05	0.000845	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.25e-05	0.000836	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	3.22e-05	0.000828	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.2e-05	0.000824	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	3.08e-05	0.000794	CbGpPWpGaD
Venlafaxine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.03e-05	0.00078	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.02e-05	0.000777	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.01e-05	0.000775	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.99e-05	0.00077	CbGpPWpGaD
Venlafaxine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.99e-05	0.000769	CbGpPWpGaD
Venlafaxine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.98e-05	0.000766	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.96e-05	0.000762	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.89e-05	0.000745	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.84e-05	0.00073	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.82e-05	0.000727	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.81e-05	0.000724	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.8e-05	0.00072	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.79e-05	0.000718	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.72e-05	0.000701	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.58e-05	0.000665	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	2.57e-05	0.000661	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	2.54e-05	0.000655	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.34e-05	0.000603	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.32e-05	0.000597	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.32e-05	0.000597	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.28e-05	0.000586	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.17e-05	0.00056	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.15e-05	0.000554	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.12e-05	0.000546	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.12e-05	0.000546	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.11e-05	0.000544	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.06e-05	0.000531	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.97e-05	0.000508	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.95e-05	0.000502	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.94e-05	0.000501	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.93e-05	0.000498	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.93e-05	0.000496	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.9e-05	0.00049	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.85e-05	0.000478	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.84e-05	0.000475	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.79e-05	0.000462	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.78e-05	0.000458	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.78e-05	0.000457	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.68e-05	0.000432	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.62e-05	0.000417	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.6e-05	0.000413	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.56e-05	0.000403	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.55e-05	0.0004	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.47e-05	0.000379	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.46e-05	0.000376	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.46e-05	0.000376	CbGpPWpGaD
Venlafaxine—NPY1R—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.46e-05	0.000376	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000368	CbGpPWpGaD
Venlafaxine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.39e-05	0.000359	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.33e-05	0.000343	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.27e-05	0.000327	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.18e-05	0.000303	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.17e-05	0.000302	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.14e-05	0.000293	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.05e-05	0.00027	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1e-05	0.000258	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	9.63e-06	0.000248	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.13e-06	0.000235	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	8.62e-06	0.000222	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.61e-06	0.000222	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.4e-06	0.000216	CbGpPWpGaD
Venlafaxine—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.05e-06	0.000207	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.92e-06	0.000204	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.91e-06	0.000204	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.85e-06	0.000202	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.72e-06	0.000199	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.28e-06	0.000187	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.21e-06	0.000186	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	6.51e-06	0.000168	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	6.35e-06	0.000164	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	5.99e-06	0.000154	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	5.94e-06	0.000153	CbGpPWpGaD
Venlafaxine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.9e-06	0.000152	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.18e-06	0.000133	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.76e-06	0.000123	CbGpPWpGaD
Venlafaxine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.46e-06	0.000115	CbGpPWpGaD
Venlafaxine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.35e-06	0.000112	CbGpPWpGaD
Venlafaxine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.1e-06	0.000106	CbGpPWpGaD
Venlafaxine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.07e-06	0.000105	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.91e-06	0.000101	CbGpPWpGaD
Venlafaxine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.68e-06	6.91e-05	CbGpPWpGaD
